3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
9
Lymphoid
5
Plasma cell
2
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Motor Activity
28
Colorectal Neoplasms
24
Colonic Neoplasms
16
Pancreatic Neoplasms
11
Neoplasms
11
Rectal Neoplasms
10
Breast Neoplasms
9
Stomach Neoplasms
7
Esophageal Neoplasms
6
Prostatic Neoplasms
4
Lung Neoplasms
3
Liver Neoplasms
3
Postoperative Complications
2
Ovarian Neoplasms
2
Gastrointestinal Neoplasms
2
Disease
2
Weight Loss
1
Urinary Incontinence
1
Thyroid Neoplasms
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Risk Reduction Behavior
1
Psychological Well-Being
1
Peripheral Nervous System Diseases
1
Patient Compliance
1
Pancreas Adenocarcinoma
1
Obesity
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mesothelioma
1
Interventions
Psychiatric Rehabilitation
2
Methods
2
Early Intervention, Educational
2
Counseling
2
Bupropion
2
tanespimycin
1
ruxolitinib
1
rucaparib
1
pembrolizumab
1
motexafin gadolinium
1
ixabepilone
1
abiraterone
1
Zinc Oxide
1
Varenicline
1
Urinalysis
1
Uncertainty
1
Tobacco Use Cessation Devices
1
Tissue Banks
1
Tinzaparin
1
Surveys and Questionnaires
1
Psychosocial Intervention
1
Psychology, Positive
1
Polymerase Chain Reaction
1
Palliative Care
1
Paclitaxel
1
Observation
1
Nicotine Replacement Therapy
1
Nicotine
1
Interleukin-15
1
INCB057643
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia
×
Exercise
×
Gastrointestinal
×
Clear all
NCT02796365
2018-12-13
HF-PROACTIVE
Henry Ford Health System
Phase NA
Completed
29 enrolled